You are here

Endoscopically-guided optical coherence tomography for early cancer screening

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41CA132256-01
Agency Tracking Number: CA132256
Amount: $287,883.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: N/A
Solicitation Number: PHS2007-2
Timeline
Solicitation Year: 2008
Award Year: 2008
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
PHYSICAL SCIENCES INC 20 NEW ENGLAND BUSINESS CENTER
ANDOVER, MA 01810
United States
DUNS: 073800062
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 () -
Business Contact
Phone: (978) 689-0003
Email: sasso@psicorp.com
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): This proposal addresses a need for an improved technology for early cancer detection and rapid screening. Recent advances in nanotechnology and high resolution imaging have led to the development of new investigative t
ools capable of probing biological tissues at the cellular level. These tools can be used to localize abnormal neoplastic cells and expedite the screening process. Physical Sciences Inc. (PSI), in collaboration with Northeastern University (NEU), proposes
to develop a technology that could be used for screening of early stage epithelial pre-cancerous lesions. Enhanced-contrast high-resolution optical coherence tomography (OCT) imaging based on tumor targeted delivery of microparticles will be used to locali
ze abnormal lesions within the tissue. Gold coated microparticles functionalized with epithelial cell specific targeting ligands will be evaluated in vitro and in vivo for specific binding to epithelial targets for early cancer diagnosis. In Phase I, this
technology will be tested on various colon cancer cell lines in cultures and in an orthotopic human colon model in mice upon topical administration. The Phase I results and observations will be used to improve the technology in Phase II. A pilot clinical i
n vivo study on an animal model will be performed to test the effectiveness of this technology.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government